The new HTA guides 2017 could be up to their predecessors

From the first reports, back in 1920, we have studied, recognized and documented the excess of events associated with arterial hypertension. This linear relationship between the level of blood pressure and the risk of stroke, is evident in all adults beyond age, sex or race, transforming high blood pressure into the highest target of global public health.

Las nuevas guías Europeas de Hipertensión contrastan con las Americanas

The greatest impact of reducing hypertension was observed in adults between 60 and 74 years, where a decrease in systolic pressure from 148 to 129 mm Hg led to a 50% reduction in stroke risk, and a decrease from 188 to 156 mm Hg to a reduction of 90% of the risk!


Read also: New High Blood Pressure Guidelines.


These lower levels of blood pressure observed were, obviously, thanks to the pharmacological treatment of this age group. However, lower levels were also observed in the group between 20 and 29 years, which suggests that prevention and non-pharmacological treatment are also very effective.

From the end of the 90s until 2017, the evidence from randomized clinical studies and epidemiological studies was incorporated into the guidelines to detect, treat, control and prevent hypertension in the most effective way possible.

With each new guide that redefined objectives and improved treatment protocols, a decrease in the population’s blood pressure and a reduction in stroke risk was observed. These improvements cannot be attributed to the guidelines themselves, but rather to the implementation by doctors of their recommendations in daily clinical practice.


Read also: Patients with Resistant Hypertension: Nearly 50% doesn’t take medication.


The reduction in the risk of stroke due to the decrease in blood pressure has been proposed as the greatest achievement of public health in the last 50 years. This achievement is not more than the result of the application in daily clinical practice of recommendations based on evidence and adherence to treatment by patients.

We hope that the ambitious recommendations of the new hypertension guidelines of 2017 can continue with the trend of their predecessors, since there is still a huge potential in improving the cerebrovascular health of the population.

Original title: Implications of New High Blood Pressure Guidelines for Stroke Primary and Secondary Prevention.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is abdominal aortic aneurysm screening cost-effective in women?

Although ultrasound screening for abdominal aortic aneurysm (AAA) is a well-established strategy in men over 65 years of age, its value in women remains...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...